Wealth & Finance International - January 2017

Wealth & Finance International 56 Accessible Treatment and Prevention Options he company’s business model focuses on emerging market opportunities spearheaded by the growth of a new market sector positioned between high-cost, high-risk, ethical pharmaceuticals and commoditised classic nutraceuticals/ supplements. The company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a competitive, differential ad- vantage. Herborium harvests its therapeutic candidates from traditional natural medicine resources, and also develops its own formulations based on a combination of herbaceutical science and standard western drug development practices. With the global nutraceutical market valued at ~$250 billion in 2016 and expected to reach ~$385 billion by 2021, Herborium offers a robust business model designed to capitalise on this rapidly growing and evolving market opportunities in the healthcare sector. Due to the unique blend of management’s expertise, it’s diversified proprietary Botanical Therapeutics® portfolio and innovative market development strategies Herborium is ideally positioned to take advantage of these opportunities while complying with changing regulatory and manufac- turing demands. AcnEase® The Company’s flagship product is AcnEase®, (www.acnease.com and www.acnease.fr) a proprietary, all botanical acne treatment for all forms of acne. In addition, AcnEase has been shown to improve conditions associated with Rosacea. The safety and efficacy of AcnEase has been demonstrated by initial clinical and preclinical testing and validated by consumer use. The results from the clinical studies demonstrated >96% improvement in both men and women with acne, which has been rein- forced with consumer data reflecting over 98% satisfaction rate. A key distinguishing characteristic of AcnEase aside from its remarkable safety profile is the products ability to prevent acne pimples from form- ing. The existing alternatives in the market for acne are limited to topical agents, systemic antibiotics, and retinoic acid or vitamin A based products (Accutane/isotretinoin) ,which while improving existing acne are associated with a wide range of side effects or even, as Accutane (isotretinoin), a subject of Class Action Suit in the USA and number of markets withdrawals. With close to 145 million people affected by acne within North America and Europe; with an additional 17 million Amer- icans and >35 million Europeans suffering from Rosacea, the market opportunity is enormous. 75% of all individuals will have acne sometime in their life. AcnEase has generated over $8 million in sales to date. Herborium’s Immediate Product Pipeline - Sexual Enhancement Formulas Herborium’s Botanical Therapeutics® products for women (Lasting Pleasure) and men (Lasting Power) meet a growing interest in natural, safe sexual health products. Lasting Pleasure addresses the high demand for a ‘Viagra-like’ product for women. For female sexual dissat- isfaction or dysfunction there currently is only Addyi. This recently approved drug has severe label restrictions and health concerns aside from questionable efficacy (10% better than placebo), Even with these limitations’ Sprout Pharmaceuticals, the company that developed Addyi, was purchased by Valeant Pharmaceutical for $1B. Sales projections for Addyi in 2016 range from $110-$150 million. The sole alternatives are topical agents and lubricants which have no impact on libido or female physical function. The female sexual enhancement industry is expected to grow into a multibillion dollar business. Sales of personal lubricants soared 52% to $61.2 million, according to Information Resources Inc. There is no safe and natural product on the market which is taken systemically to improve libido or sexual satisfaction. Lasting Power is distinct from all current Rx medicines for erectile dysfunction (ED) which all have the same mechanism of action (MOA). Due to their common MOA, these ED products have cardiovascular side effects that preclude use by men taking a wide range of cardiovascular medications. Lasting Power contains concentrated herbal extracts that are safe and work to stimulate and prolong a man’s erection in a sexu- ally conducive environment. The single use sachet allows for sponta- neous, discreet use for those looking to enhance their sexual experience or more chronic use is beneficial for those with mild ED. The market for pharmaceutical grade sexual health products is over $3.2 billion worldwide with Viagra (Pfizer), Cialis (Eli Lilly) and Levitra Herborium Group, Inc a Botanical Therapeutics® company with a mission to bring the power of cutting edge herbal medicine to mainstream healthcare. We develop, license, and market proprietary, botanical based medicinal products to consumers and healthcare professionals. T 1701WF14